OraSure Technologies, Inc. has announced the availability of the OraQuick® In-Home HIV Test at retailers nationwide and online, making it the first rapid infectious disease test ever to be made available directly to consumers for in-home use.
“For the first time ever, individuals now have access to an in-home rapid oral HIV test – the same test healthcare professionals have used and trusted for years – that will empower them to learn their HIV status in the comfort and privacy of their own home,” said Douglas A. Michels, President and Chief Executive Officer of OraSure Technologies. “This is a tremendous breakthrough in our fight against HIV and AIDS.”
The OraQuick® In-Home HIV Test detects antibodies to both HIV-1 and HIV-2 with an oral swab, providing a confidential in-home testing option with results in as little as 20 minutes. The in-home test is an over-the-counter version of OraQuick ADVANCE®, an oral swab rapid test with more than 25 million units sold in the professional market, including doctors, hospitals, clinics and other trained professionals.
“To ensure optimal support for individuals using the OraQuick® In-Home HIV Test, OraSure is making available specialized resources including live support and comprehensive referral services 24 hours a day, seven days a week, every day of the year, through a toll-free support center and comprehensive consumer website,” said Debra Fraser-Howze, VP of Government Affairs for OraSure.
The OraQuick® Support Center is staffed with bi-lingual (English/Spanish) representatives who are available by telephone at 866-436-6527 to answer questions about HIV/AIDS and using and interpreting the test. They also provide referrals to follow-up and care, and they can also take orders for the OraQuick In-Home HIV Test. Additionally, the product website provides access to resources and referral to follow-up counseling, confirmatory testing and medical care.
Visit OraQuick.com for more information.